MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
InspireMD Market Cap 2011-2026 | NSPR
As of May 17, 2026 InspireMD has a market cap of $ 67.5 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap InspireMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115 M | 75.1 M | 63.6 M | 8.74 M | 22.2 M | 15.7 M | 2.47 M | 4.15 M | 371 K | 99.1 K | 116 K | 900 K | 2.3 M | 1.63 B | 2.92 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.63 B | 99.1 K | 130 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
316 M | $ 11.64 | -8.85 % | $ 330 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 4.17 | 0.97 % | $ 156 M |  France |
 |
Apyx Medical Corporation
APYX
|
142 M | $ 4.05 | -7.11 % | $ 166 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 7.66 | 1.19 % | $ 1.15 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.3 | -3.77 % | $ 1.4 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 17.72 | -1.01 % | $ 416 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.54 | -4.97 % | $ 66.2 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.27 | -5.22 % | $ 51.7 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.5 | -8.16 % | $ 31.1 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 70.0 | -2.33 % | $ 3.82 B |  Britain |
 |
MiMedx Group
MDXG
|
779 M | $ 3.56 | 0.28 % | $ 526 M | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 11.07 | -3.4 % | $ 397 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.01 | - | $ 17.1 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.91 | 2.49 % | $ 38.1 M | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 12.01 | -2.28 % | $ 476 M |  Curacao |
 |
Electromed
ELMD
|
175 M | $ 35.68 | -2.25 % | $ 302 M | USA |
 |
Butterfly Network
BFLY
|
946 M | $ 3.83 | -6.59 % | $ 811 M | USA |
 |
Insulet Corporation
PODD
|
18.1 B | $ 147.46 | -0.82 % | $ 10.4 B | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.27 | -5.62 % | $ 6.3 M | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 76.64 | -0.74 % | $ 10.4 B | USA |
 |
Profound Medical Corp.
PROF
|
166 M | $ 6.97 | -3.19 % | $ 211 M | Canada |
 |
Stryker Corporation
SYK
|
147 B | $ 306.76 | 0.41 % | $ 117 B | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 35.49 | -2.34 % | $ 1.1 B | USA |
 |
Tactile Systems Technology
TCMD
|
640 M | $ 22.74 | -1.3 % | $ 520 M | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 40.05 | -6.12 % | $ 1.18 B | USA |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 12.82 | -9.4 % | $ 872 M | USA |